These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9822065)

  • 21. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic therapy in valvular heart disease.
    Levine HJ; Pauker SG; Salzman EW
    Chest; 1989 Feb; 95(2 Suppl):98S-106S. PubMed ID: 2644107
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined rheumatic and congenital heart disease in adult patients.
    Befeler B; Hildner FJ; Cohen LS; Javier RP; Samet P
    J Fla Med Assoc; 1971 Dec; 58(12):24-7. PubMed ID: 5121862
    [No Abstract]   [Full Text] [Related]  

  • 24. The floppy mitral valve.
    Lucas RV; Edwards JE
    Curr Probl Cardiol; 1982 Jul; 7(4):1-48. PubMed ID: 7116912
    [No Abstract]   [Full Text] [Related]  

  • 25. [Atrial septal associated with mitral valve prolapse and bacterial endocarditis].
    Ogawa S
    Kokyu To Junkan; 1979 Oct; 27(10):1120-1. PubMed ID: 504823
    [No Abstract]   [Full Text] [Related]  

  • 26. Mitral valve prolapse and thromboembolic events.
    Abinader EG
    Isr Med Assoc J; 2001 Jul; 3(7):550. PubMed ID: 11791434
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet survival time and thromboembolism in patients with mitral valve prolapse.
    Steele P; Weily H; Rainwater J; Vogel R
    Circulation; 1979 Jul; 60(1):43-5. PubMed ID: 445732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current epidemiological characteristics of infectious endocarditis].
    Crociani P; Schivazappa L
    G Ital Cardiol; 1990 Jan; 20(1):66-71. PubMed ID: 2184073
    [No Abstract]   [Full Text] [Related]  

  • 29. Mitral insufficiency in subjects 50 years of age or older.
    Vlodaver Z; Edwards JE
    Cardiovasc Clin; 1973; 5(1):149-67. PubMed ID: 4604779
    [No Abstract]   [Full Text] [Related]  

  • 30. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
    Francescone S; Halperin JL
    J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567
    [No Abstract]   [Full Text] [Related]  

  • 31. [The thromboembolic syndrome in the surgery of rheumatic heart defects].
    Uglov FG; Krutikova IF; Podozerskaia EN; Burmistrova MM; Rassadina SV
    Vestn Khir Im I I Grek; 1991 Apr; 146(4):3-7. PubMed ID: 1661942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute disorders of the mesenteric circulation among heart defect patients].
    Gagarin VV
    Kardiologiia; 1984 Aug; 24(8):81-4. PubMed ID: 6492589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic therapy in valvular heart disease.
    Levine HJ; Pauker SG; Salzman EW; Eckman MH
    Chest; 1992 Oct; 102(4 Suppl):434S-444S. PubMed ID: 1395827
    [No Abstract]   [Full Text] [Related]  

  • 34. [Proceedings: Prolapse of the posterior leaflet of the mitral valve associated with atrial septal defects in sisters].
    Sato T; Goto K; Imano K; Komatsu Y; Shibuya M
    Jpn Circ J; 1975 Jun; 39(6):724. PubMed ID: 1152211
    [No Abstract]   [Full Text] [Related]  

  • 35. Antithrombotic therapy for coronary artery disease and valvular heart disease.
    Israel DH; Fuster V; Chesebro JH; Badimon L
    Baillieres Clin Haematol; 1990 Jul; 3(3):705-43. PubMed ID: 2271788
    [No Abstract]   [Full Text] [Related]  

  • 36. [The assessment of the thromboembolic risk and the role of antithrombotic prophylaxis in nonrheumatic atrial fibrillation].
    Fera MS; Giovannini E
    G Ital Cardiol; 1999 Feb; 29(2):193-213. PubMed ID: 10088078
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors for infective endocarditis.
    Steckelberg JM; Wilson WR
    Infect Dis Clin North Am; 1993 Mar; 7(1):9-19. PubMed ID: 8463656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology].
    Gohlke-Bärwolf C; Acar J; Oakley C; Butchart E; Burckhardt D; Delahaye JP; Horstkotte D; Bodnar E; Hall R; Kremer R
    Z Kardiol; 1995 Dec; 84(12):1018-32. PubMed ID: 8578786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular disease in patients with retinal arterial occlusion.
    Wilson LA; Warlow CP; Russell RW
    Lancet; 1979 Feb; 1(8111):292-4. PubMed ID: 84946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.